NASDAQ (USD): Aerovate Therapeutics, Inc. (AVTE)
Last Price
1.67
Today's Change
+0.019 (1.14%)
Day's Change
1.62 - 1.69
Trading Volume
381,366
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
12
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
NordFX Weekly Forecast
Forex and Cryptocurrency Forecast for 01 – 05 July 2024
2
NordFX News
June Results: Gold Brings Astronomical Profits to NordFX's Top 3 Traders
3
CEO Morning Brief
Tesla Is About to Lose Its EV Market Majority in the US
4
Amazon Plans Discount Web Store in Effort to Counter China's Temu, Shein
5
Amazon Hits US$2 Tril in Value as AI Frenzy Fuels Rally
#
Stock
Score
SQQQ
ProShares UltraPro Short QQQ
TQQQ
ProShares UltraPro QQQ
625
CSLR
Complete Solaria, Inc.
250
BAC
Bank of America Corporation
187
NVDA
NVIDIA Corporation
137
6
AGN
125
7
IRIS
8
RIO
Rio Tinto Group
9
CBM
10
LGND
Ligand Pharmaceuticals Incorporated
Last
Change
Volume
SNTI
0.506
+0.23
181,600,868
LMDX
0.016
-0.018
120,553,903
121.78
-1.76
100,334,512
1.60
+0.481
95,545,335
762.00
-84.71
85,558,284
MU
132.23
-10.13
65,857,209
GDHG
0.17
+0.019
61,688,370
XTIA
0.423
-0.019
56,645,274
8.27
-0.005
42,602,658
TSLA
209.71
+11.83
41,930,663
AMR
320.93
+40.40
140,419
MSTR
1,405.00
+27.52
452,463
COKE
1,107.15
+22.15
10,963
UFPT
280.00
+16.129
21,707
FCNCA
1,698.29
+14.68
7,618
REGN
1,065.27
+14.24
104,539
FNGU
458.12
+13.01
311,377
ARCH
165.17
+12.94
121,354
VRTX
477.47
+8.75
191,133
BRK-A
610,930.00
-1,311.00
1,009
1,065.03
-227.94
2,455,399
MELI
1,629.32
-188.66
1,851,535
AZO
2,842.41
-121.681
43,487
MKL
1,395.13
-102.30
318,280
NOW
643.29
-87.83
5,025,012
MDB
236.06
-73.94
10,812,930
1,581.52
-61.875
86,344
BKNG
3,922.07
-39.43
27,443
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....